You are here

  • Home
  • Archive
  • Volume 77, Issue 4
  • Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding to …

Citation Tools

Article menu

Download PDFPDF

Clinical and epidemiological research
Extended report
Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding to methotrexate

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Matsuno H, Tomomitsu M, Hagino A, et al
Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding to methotrexate
Annals of the Rheumatic Diseases 2018;77:488-494.